CASE REPORT
Microsecond Laser For Chronic Central Serous Chorioretinopathy
PRESENTING AUTHOR
Eduardo Zans
-
Amy Pérez,Z vision Eye centre Director Chieff of Retina department ASRS member
-
Carlos Hanampa,Z vision Eye centre Director Chieff of Retina department ASRS member
-
Purpose:
To demonstrate the safety and effectiveness of the semiconductor laser (green) with a wavelength of 520 nm in its microsecond mode, as a treatment of chronic central serous choroidopathy.
-
Case Report:
With a power of 400 mW, pulse duration of 200 ms, intervals of pulse off on grid, spot size 100 microns with volk transequator lens was performed in 4 patients as a treatment of chronic central serous choroidopathy.
-
Discussion:
Often, the disease shows no improvement after 3 months from the first episode of central serous choroidopathy. In these cases, laser treatment can be beneficial, as it can be applied to the macular region, at leakage points, and also in the form of a grill on the healthy pigment epithelium. A series of cases have been carried out to demonstrate the safety and effectiveness of the 520 nm green laser in microsecond mode.
-
Conclusions:
Laser (green) with a wavelength of 520 nm in its microsecond mode, is an effective alternative to treat chronic central serous choroidopathy.
The authors have no financial interests in any material discussed in this article. There are no conflicts of interest to disclose.